maritide obesity drug news - Search News

Amgen, Obesity

The New York Times on MSN · 4d

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month,

CNBC on MSN · 4d

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

BioPharma Dive · 4d

Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound.

16hon MSN

Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

2don MSN

Amgen Obesity Drug More Effective Than Competitors

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

Amgen's big reveal of obesity data falls a bit flat

William Blair's assessment is that MariTide is an improvement on current obesity therapies with a profile that "will be ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results